| __timestamp | Bio-Techne Corporation | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 60716000 | 165772000 |
| Thursday, January 1, 2015 | 119401000 | 196614000 |
| Friday, January 1, 2016 | 140879000 | 303251000 |
| Sunday, January 1, 2017 | 199243000 | 366406000 |
| Monday, January 1, 2018 | 240636000 | 434407000 |
| Tuesday, January 1, 2019 | 264359000 | 468711000 |
| Wednesday, January 1, 2020 | 260583000 | 516922000 |
| Friday, January 1, 2021 | 324951000 | 739560000 |
| Saturday, January 1, 2022 | 372766000 | 1002140000 |
| Sunday, January 1, 2023 | 378378000 | 1161300000 |
| Monday, January 1, 2024 | 396826000 | 1242157000 |
Igniting the spark of knowledge
In the ever-evolving biotech industry, effective cost management is crucial for sustained growth. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Incyte Corporation and Bio-Techne Corporation from 2014 to 2023. Over this period, Incyte's SG&A expenses surged by approximately 600%, peaking at over $1.16 billion in 2023. In contrast, Bio-Techne's expenses grew by around 550%, reaching nearly $397 million in 2023. This trend highlights Incyte's aggressive expansion strategy, while Bio-Techne maintains a steady growth trajectory. Notably, data for 2024 is incomplete, indicating potential shifts in financial strategies. As these companies navigate the competitive landscape, understanding their cost management strategies offers valuable insights into their operational priorities and market positioning.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Bio-Techne Corporation
Who Optimizes SG&A Costs Better? AstraZeneca PLC or Incyte Corporation
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Incyte Corporation
Breaking Down SG&A Expenses: Zoetis Inc. vs Bio-Techne Corporation
GSK plc or Incyte Corporation: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of argenx SE and Bio-Techne Corporation
Breaking Down SG&A Expenses: Incyte Corporation vs Insmed Incorporated
Breaking Down SG&A Expenses: Incyte Corporation vs Walgreens Boots Alliance, Inc.
Selling, General, and Administrative Costs: Incyte Corporation vs Verona Pharma plc
Incyte Corporation and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Bio-Techne Corporation or Ultragenyx Pharmaceutical Inc.
Selling, General, and Administrative Costs: Bio-Techne Corporation vs Viridian Therapeutics, Inc.